NORGES BANK - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 118 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,892,000
+253.0%
553,300
+37.4%
0.00%
Q2 2016$536,000
-79.7%
402,625
-19.5%
0.00%
-100.0%
Q1 2016$2,636,000
-32.9%
500,0920.0%0.00%
-50.0%
Q4 2015$3,926,000
-7.1%
500,0920.0%0.00%0.0%
Q3 2015$4,226,000
+21.4%
500,092
+57.2%
0.00%0.0%
Q2 2015$3,482,000
-13.6%
318,079
+10.3%
0.00%0.0%
Q1 2015$4,032,000
-2.9%
288,379
+17.3%
0.00%0.0%
Q4 2014$4,154,000
-9.8%
245,918
-28.4%
0.00%0.0%
Q3 2014$4,607,000
-47.3%
343,291
-50.0%
0.00%0.0%
Q2 2014$8,748,000
+114.3%
686,582
+100.0%
0.00%0.0%
Q1 2014$4,082,000
-13.9%
343,2910.0%0.00%
-33.3%
Q4 2013$4,741,000
-20.9%
343,2910.0%0.00%0.0%
Q3 2013$5,990,000
+51.5%
343,291
+41.1%
0.00%
+50.0%
Q2 2013$3,954,000
+181.2%
243,328
+739.0%
0.00%
+100.0%
Q1 2013$1,406,00029,0020.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders